Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Linde

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Cardiovascular Research|September 13, 2019
The Membership Committee of the ESCCecilia Linde,
Heart (British Cardiac Society)|January 20, 2004
Implantable cardioverter-defibrillator treatment and resynchronisation in heart failureCecilia Linde
European Heart Journal|August 26, 2023
The BUDAPEST trial: a good grade for upgrades in heart failure with reduced ejection fractionCecilia Linde
European Journal of Heart Failure|November 5, 2014
How do patients with previous RV pacing respond to upgrading to CRT? Important messages for pacemaker and ICD follow-upCecilia Linde
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 28, 2014
When cardiac resynchronization therapy may be harmful: time to wake upCecilia Linde
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 29, 2009
Cardiac resynchronization therapy in mild heart failureCecilia Linde
European Heart Journal|May 5, 2022
CRT-P or CRT-D in heart failure patients: the RESET-CRT project-a prelude to the randomized controlled RESET-CRT studyCecilia Linde
Current Heart Failure Reports|May 8, 2008
Future directions in cardiac resynchronization therapyCecilia Linde
Lancet (London, England)|August 27, 2023
Will the results from the AdaptResponse trial boost CRT use?Cecilia Linde
European Heart Journal|October 6, 2021
Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trialCecilia Linde
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Cardiovascular Research|September 13, 2019
The Membership Committee of the ESCCecilia Linde,
Heart (British Cardiac Society)|January 20, 2004
Implantable cardioverter-defibrillator treatment and resynchronisation in heart failureCecilia Linde
European Heart Journal|August 26, 2023
The BUDAPEST trial: a good grade for upgrades in heart failure with reduced ejection fractionCecilia Linde
European Journal of Heart Failure|November 5, 2014
How do patients with previous RV pacing respond to upgrading to CRT? Important messages for pacemaker and ICD follow-upCecilia Linde
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 28, 2014
When cardiac resynchronization therapy may be harmful: time to wake upCecilia Linde
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 29, 2009
Cardiac resynchronization therapy in mild heart failureCecilia Linde
European Heart Journal|May 5, 2022
CRT-P or CRT-D in heart failure patients: the RESET-CRT project-a prelude to the randomized controlled RESET-CRT studyCecilia Linde
Current Heart Failure Reports|May 8, 2008
Future directions in cardiac resynchronization therapyCecilia Linde
Lancet (London, England)|August 27, 2023
Will the results from the AdaptResponse trial boost CRT use?Cecilia Linde
European Heart Journal|October 6, 2021
Pace and ablate better than drugs in patients with heart failure and atrial fibrillation: lessons from the APAF-CRT mortality trialCecilia Linde
Pageof 30